Michael Bowen,Herren Wu,William Dall'Acqua,Peter Kiener,Bahija Jallal,Anthony Coyle,William DallAcqua
申请号：
US14253161
公开号：
US20140302058A1
申请日:
2014.04.15
申请国别(地区):
US
年份:
2014
代理人:
摘要：
The present invention provides human anti-IL-6 antibodies with extended in vivo half-life. The invention further relates to pharmaceutical compositions, therapeutic compositions, and methods using therapeutic antibodies that bind to IL-6 and that has an extended in vivo half-life for the treatment and prevention of IL-6 mediated diseases and disorders, such as, but not limited to, inflammatory diseases and disorders, autoimmune diseases and disorders and tumors.
